These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1135 related articles for article (PubMed ID: 26708045)

  • 21. Significance of size of lymph node metastasis on postsurgical stimulated thyroglobulin levels after prophylactic unilateral central neck dissection in papillary thyroid carcinoma.
    Lang BH; Tang AH; Wong KP; Shek TW; Wan KY; Lo CY
    Ann Surg Oncol; 2012 Oct; 19(11):3472-8. PubMed ID: 22565664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-Dose RAI Therapy Justified by Pathological N1a Disease Revealed by Prophylactic Central Neck Dissection for cN0 Papillary Thyroid Cancer Patients: Is it Superior to Low-Dose RAI Therapy?
    Wei L; Bai L; Zhao L; Yu T; Ma Q; Ji B
    World J Surg; 2019 May; 43(5):1256-1263. PubMed ID: 30684002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Excellent Prognosis of Central Lymph Node Recurrence-Free Survival for cN0M0 Papillary Thyroid Carcinoma Patients Who Underwent Routine Prophylactic Central Node Dissection.
    Ito Y; Miyauchi A; Masuoka H; Fukushima M; Kihara M; Miya A
    World J Surg; 2018 Aug; 42(8):2462-2468. PubMed ID: 29372373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-risk papillary thyroid carcinoma patients who underwent near-total thyroidectomy without prophylactic central compartment lymph node dissection and were ablated with low-dose 50mCi RAI had excellent 10-year prognosis.
    Michalaki M; Bountouris P; Roupas ND; Theodoropoulou A; Agalianou N; Alexandrides T; Markou K
    Hormones (Athens); 2016 Oct; 15(4):511-517. PubMed ID: 28222412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The need of prophylactic central lymph node dissection is controversial in terms of postoperative thyroglobulin follow-up of patients with cN0 papillary thyroid cancer.
    Korkmaz MH; Öcal B; Saylam G; Çakal E; Bayır Ö; Tutal E; Tatar EÇ
    Langenbecks Arch Surg; 2017 Mar; 402(2):235-242. PubMed ID: 28224278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioactive iodine (RAI) therapy for distantly metastatic differentiated thyroid cancer (DTC) in juvenile versus adult patients.
    Kammori M; Fukumori T; Sugishita Y; Hoshi M; Shimizu K; Yamada T
    Endocr J; 2015; 62(12):1067-75. PubMed ID: 26424174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The significance and the predictive factors of microscopic lymph node metastasis in patients with clinically node negative papillary thyroid cancer: A retrospective cohort study.
    Noda S; Onoda N; Morisaki T; Kashiwagi S; Takashima T; Hirakawa K
    Int J Surg; 2015 Aug; 20():52-7. PubMed ID: 26079502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioactive iodine ablation may not decrease the risk of recurrence in intermediate-risk papillary thyroid carcinoma.
    Kim SK; Woo JW; Lee JH; Park I; Choe JH; Kim JH; Kim JS
    Endocr Relat Cancer; 2016 May; 23(5):367-76. PubMed ID: 26917553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-operative stimulated thyroglobulin and neck ultrasound as personalized criteria for risk stratification and radioactive iodine selection in low- and intermediate-risk papillary thyroid cancer.
    Orlov S; Salari F; Kashat L; Freeman JL; Vescan A; Witterick IJ; Walfish PG
    Endocrine; 2015 Sep; 50(1):130-7. PubMed ID: 25792004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determining the extent of lateral neck dissection necessary to establish regional disease control and avoid reoperation after previous total thyroidectomy and radioactive iodine for papillary thyroid cancer.
    Wu G; Fraser S; Pai SI; Farrag TY; Ladenson PW; Tufano RP
    Head Neck; 2012 Oct; 34(10):1418-21. PubMed ID: 22052539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic Central Neck Dissection Might Not Be Necessary in Papillary Thyroid Carcinoma: Analysis of 11,569 Cases from a Single Institution.
    Kim SK; Woo JW; Lee JH; Park I; Choe JH; Kim JH; Kim JS
    J Am Coll Surg; 2016 May; 222(5):853-64. PubMed ID: 27113516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma.
    Yang Z; Flores J; Katz S; Nathan CA; Mehta V
    Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy.
    Vassilopoulou-Sellin R; Schultz PN; Haynie TP
    Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response to Treatment is Highly Predictable in cN0 Patients with Papillary Thyroid Carcinoma.
    Gorshtein A; Benbassat C; Robenshtok E; Shimon I; Hirsch D
    World J Surg; 2016 Sep; 40(9):2123-30. PubMed ID: 27094559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival in patients with papillary thyroid cancer is not affected by the use of radioactive isotope.
    Podnos YD; Smith DD; Wagman LD; Ellenhorn JD
    J Surg Oncol; 2007 Jul; 96(1):3-7. PubMed ID: 17567872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of socioeconomic status on the use of adjuvant radioactive iodine for papillary thyroid cancer.
    Zevallos JP; Xu L; Yiu Y
    Thyroid; 2014 Apr; 24(4):758-63. PubMed ID: 24378070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radioactive iodine in low- to intermediate-risk papillary thyroid cancer.
    Zhao H; Gong Y
    Front Endocrinol (Lausanne); 2022; 13():960682. PubMed ID: 36034423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland.
    Byeon HK; Ban MJ; Lee JM; Ha JG; Kim ES; Koh YW; Choi EC
    Ann Surg Oncol; 2012 Dec; 19(13):4259-61. PubMed ID: 23070784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can intraoperative frozen section influence the extension of central neck dissection in cN0 papillary thyroid carcinoma?
    Raffaelli M; De Crea C; Sessa L; Giustacchini P; Bellantone R; Lombardi CP
    Langenbecks Arch Surg; 2013 Mar; 398(3):383-8. PubMed ID: 23207498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Significance of selective neck dissection in patients with cN0 thyroid carcinoma].
    Li ZJ; An CM; Yan DG; Zhang XW; Zhang ZM; Xu ZG; Tang PZ
    Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):783-6. PubMed ID: 24378103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.